Breast Cancer Treatments Might Speed Aging, Study Finds
By Ernie Mundell HealthDay Reporter
TUESDAY, Oct. 8, 2024 -- Any form of breast cancer treatment appears to speed the aging of the recipient's cells, a new study finds.
“For the first time, we're showing that the [aging] signals we once thought were driven by chemotherapy are also present in women undergoing radiation and surgery,” said study lead author Judith Carroll.
“While we expected to see increased gene expression linked to biological aging in women who received chemotherapy, we were surprised to find similar changes in those who only underwent radiation or surgery," said Carroll. She's an associate professor of psychiatry and biobehavioral sciences at the University of California Los Angeles (UCLA), as well as an investigator at UCLA Health's Jonsson Comprehensive Cancer Center.
The findings were published Oct. 7 in the Journal of the National Cancer Institute.
As the researchers explained, the rigors of breast cancer have long been linked to accelerated aging. Fatigue, declines in thinking and memory and increasingly physical frailty can plague survivors.
Just how big a contributor to those declines is cancer treatment?
To find out, the UCLA team spent two years tracking the gene expression of blood cells in women undergoing breast cancer treatment. They were looking for genetic markers of cellular aging, including responses to DNA damage, cellular senescence (when cells cease dividing), and markers of inflammation.
Cellular senescence is an especially potent sign of aging, because when cells stop dividing they can release toxic substances that can harm adjacent cells.
Regardless of the type of treatment a woman was receiving for breast cancer care -- chemotherapy, radiation or surgery -- there were clear signs of inflammatory signaling and cellular senescence -- from cells, especially immune system cells, Carroll's team found. This suggests these cells were aging faster than normal.
There were also clear signs of increased DNA damage-response genes, another sign of cellular aging. These changes occurred in patients who were receiving chemotherapy as well as those who were not, the researchers noted.
Knowing that these changes are occurring might help breast cancer survivors, said study senior author Julienne Bower.
“The results suggest women who receive treatment for breast cancer have a pattern of gene expression that indicates increased DNA damage and inflammation, which could be important targets for recovering from cancer and having a better quality of life in survivorship,” said Bower, who is a member of the cancer center and a professor of psychology at UCLA.
"We’ve only just begun to understand the long-term consequences of cancer therapy and these findings are a critical step toward understanding the biological pathways that drive many post-treatment symptoms in breast cancer survivors,” Carroll added in a UCLA news release. “Our goal is to find ways to improve survivorship, not just in terms of years lived, but also in quality of life and overall health."
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-09 00:00
Read more
- Fasting at Night May Aid Glucose Metabolism in Night-Shift Workers
- History of Concussion Could Raise a New Mom's Odds for Mental Health Issues
- Expanded Admission Screening Protocol for Candida Auris Beneficial
- AskBio Receives FDA Rare Pediatric Disease and Orphan-Drug Designations for AB-1003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2I/R9
- AHA: AI Analysis of Images, Videos Can ID Early Hypertension, Diabetes
- Newer Blood Thinner, Edoxaban, Cuts Odds for Stroke After Heart Valve Surgery
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions